Georgiamune, Menarini Group, Stemline Therapeutics, GIM-621, global licensing agreement, immuno-oncology, cancer drug development, oral immunotherapy, solid tumors, biotechnology collaboration

Florence, Italy, and Gaithersburg, Maryland, United States, October 22, 2026 Georgiamune Inc. and Menarini Group, through its wholly owned...